Peptid-Pools
Peptide pools - Powerful tools for your T cell research
Peptide pools offer a very cost-efficient and effective solution for the stimulation of antigen-specific CD4+ and CD8+ T cells.
Peptide pools are based on a complete protein by splitting the primary amino acid sequence into individual 15-mer peptides, each overlapping by 11 amino acids. Each peptide is synthesized and then combined into a pool containing the complete protein including the antigen-presenting part. The pools can then be used for T-cell immunoassays.
Do you need an individual peptide pool? Send us the UniProt ID or the protein sequence to receive a quote for your individual peptide pool.
Peptidpools can be used for
- Antigen specific stimulation in T-cell assays
- Immunmonitoring - T-Zell epitope identification
- T-Cell epitope mapping
- the development of cellular therapies or immunotherapy approaches
- Vaccine development
- biological screenings
- protein-protein interaction analysis
Tetanus Toxin Peptide Pool
The Tetanus Peptide Pool consists of 326 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Tetanus toxin (UniProt ID: P04958) of Clostridium tetani (strain Massachusetts / E88) for T cell assays (e.g. ELISPOT).
One unit allows the stimulation of 2,5 x 10E8 cells.
EBV (EBNA-3a) Peptide Pool
EBV (EBNA-3a) Peptide Pool is a Pool of 234 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Epstein-Barr nuclear antigen 3 (EBNA3a) (UniProt ID: P12977) of Epstein-Barr virus (HHV4) for T cell assays.
One pack size allows the stimulation of 2,5 x 10E8 cells.
HCMVA (pp65) Peptide Pool
CMV pp65 Control Pool of 138 peptides derived from a peptide scan (15mers with 11 aa overlap) through 65 kDa phosphoprotein (pp65) (UniProtKB - P06725) of Human cytomegalovirus (HHV-5) frequently used as positive control. 15 nmol (approx. 25µg/peptide) for stimulation of 2.5 x 10E8 cells µg.
Length 65 kDa phosphoprotein: 561 amino acidsSequence:MESRGRRCPEMISVLGPISGHVLKAVFSRGDTPVLPHETRLLQTGIHVRVSQPSLILVSQYTPDSTPCHRGDNQLQVQHTYFTGSEVENVSVNVHNPTGRSICPSQEPMSIYVYALPLKMLNIPSINVHHYPSAAERKHRHLPVADAVIHASGKQMWQARLTVSGLAWTRQQNQWKEPDVYYTSAFVFPTKDVALRHVVCAHELVCSMENTRATKMQVIGDQYVKVYLESFCEDVPSGKLFMHVTLGSDVEEDLTMTRNPQPFMRPHERNGFTVLCPKNMIIKPGKISHIMLDVAFTSHEHFGLLCPKSIPGLSISGNLLMNGQQIFLEVQAIRETVELRQYDPVAALFFFDIDLLLQRGPQYSEHPTFTSQYRIQGKLEYRHTWDRHDEGAAQGDDDVWTSGSDSDEELVTTERKTPRVTGGGAMAGASTSAGRKRKSASSATACTSGVMTRGRLKAESTVAPEEDTDEDSDNEIHNPAVFTWPPWQAGILARNLVPMVATVQGQNLKYQEFFWDANDIYRIFAELEGVWQPAAQPKRRRHRQDALPGPCIASTPKKHRG
Human (SOX2) Peptide Pool
The Genaxxon Human (SOX2) Peptide Pool comes as a pool of 77 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Transcription factor SOX-2 (UniProtKB - P48431) for T cell assays.
One unit allows the stimulation of 2.5 x 10E8 cells.
Source Protein name: Transcription factor SOX-2Gene name: SOX2Organism: Homo sapiens (Human)Length: 317 amino acidsSequence:MYNMMETELKPPGPQQTSGGGGGNSTAAAAGGNQKNSPDRVKRPMNAFMVWSRGQRRKMA
QENPKMHNSEISKRLGAEWKLLSETEKRPFIDEAKRLRALHMKEHPDYKYRPRRKTKTLM
KKDKYTLPGGLLAPGGNSMASGVGVGAGLGAGVNQRMDSYAHMNGWSNGSYSMMQDQLGY
PQHPGLNAHGAAQMQPMHRYDVSALQYNSMTSSQTYMNGSPTYSMSYSQQGTPGMALGSM
GSVVKSEASSSPPVVTSSSHSRAPCQAGDLRDMISMYLPGAEVPEPAAPSRLHMSQHYQS
GPVPGTAINGTLPLSHM
M. tuberculosis esxH Peptide Pool
The M. tuberculosis esxH Peptide-Pool represents 22 peptides derived from a peptide scan (15mers with 11 aa overlap) through ESAT-6-like protein (Swiss-Prot ID: P9WNK3) - EsxH of M. Tuberculosis - strain ATCC 25618 / H37Rv.
All peptides are mixed and lyophilized before delivery offering the identified immunodominant epitopes of the tuberculosis bacteria.
PRAME/OIP4 Peptide Pool (human)
Peptide Pool of 125 overlapping peptides derived from a peptide scan (15mers with 11 aa overlap) through Melanoma antigen preferentially expressed in tumors (PRAME/OIP4) (UniProt ID: P78395) of Homo sapiens (Human).
One unit allows the stimulation of 2,5 x 10E8 cells.
Variant Omicron B.1.1.529 BA.5 Peptide Pool SARS-CoV-2 full length (Spike Glycoprotein)
This peptide pool of the omicron variant B.1.1.529 BA.5 of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) that covers the whole spike glycoprotein with all mutations.
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.The peptides of this product are supplied lyophilized as trifluoro acetate salts.
Peptide Scan 15/11Length: 1270 amino acidsMFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLKSYGFQPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT
Epsilon Variant (B.1.427/B.1.429) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)
Peptide pool with 14 peptides that covers all mutations in the Spike Glycoprotein derived from the epsilon variant B.1.427/B.1.429 of SARS-CoV-2.
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.This peptide pool is supplied lyophilized as trifluoroacetate salt.
Peptide sequences included (15 nmol (approx. 25ug)/peptide for stimulation of 2.5 x 10E8 cells):MFVFLVLLPLVSIQC AVLYQGVNCTEVPVA LVLLPLVSIQCVNLT QGVNCTEVPVAIHAD PLVSIQCVNLTTRTQ IQCVNLTTRTQLPPA LGVYYHKNNKSCMES YHKNNKSCMESEFRV NKSCMESEFRVYSSA LDSKVGGNYNYRYRL VGGNYNYRYRLFRKS YNYRYRLFRKSNLKP GTNTSNQVAVLYQGV SNQVAVLYQGVNCTE
Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
Protein ID: P0DTC2 (swiss prot)
Eta Variant (B.1.525) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the eta variant B.1.525 of SARS-CoV-2 which emerged in Angola in December 2020..
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.This peptide pool is supplied lyophilized as trifluoroacetate salt.
Peptide sequences included (15 nmol (approx. 25ug)/peptide for stimulation of 2,5 x 108 cells):KVFRSSVLHSTRDLF PFLGVHKNNKSWMES PIGAGICASYQTHTN SSVLHSTRDLFLPFF VHKNNKSWMESEFRV GICASYQTHTNSPRR HSTRDLFLPFFSNVT NKSWMESEFRVYSSA SYQTHTNSPRRARSV DLFLPFFSNVTWFHVMESEFRVYSSANNCT HTNSPRRARSVASQS PFFSNVTWFHVISGT FRVYSSANNCTFEYV LLAGTITSGWTLGAG NVTWFHVISGTNGTK YQAGSTPCNGVKGFN TITSGWTLGAGAALQ FHVISGTNGTKRFDN STPCNGVKGFNCYFPGWTLGAGAALQIPFA SGTNGTKRFDNPVLP NGVKGFNCYFPLQSY GTKRFDNPVLPFNDG GTNTSNQVAVLYQGV VIKVCEFQFCNDPFL SNQVAVLYQGVNCTE CEFQFCNDPFLGVHK AVLYQGVNCTEVPVA FCNDPFLGVHKNNKSQGVNCTEVPVAIHAD
Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
Protein ID: P0DTC2 (swiss prot)
Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein)
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2.
The peptides of this product are supplied lyophilized as trifluoroacetate salts.This pool consists of 80 peptides of the spike protein and covers onlythe mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529).
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.
Peptide sequences - total length: 1273 amino acids
DLFLPFFSNVTWFHV; RQIAPGQTGNIADYN; VAVLYQGVNCTEVPV; PFFSNVTWFHVISGT; PGQTGNIADYNYKLP; YQGVNCTEVPVAIHA; NVTWFHVISGTNGTK;GNIADYNYKLPDDFT; QTRAGCLIGAEYVNN; FHVISGTNGTKRFDN; DFTGCVIAWNSNKLD; GCLIGAEYVNNSYEC; VLPFNDGVYFASIEK; CVIAWNSNKLDSKVS;GAEYVNNSYECDIPI; NDGVYFASIEKSNII; WNSNKLDSKVSGNYN; AGICASYQTQTKSHR; YFASIEKSNIIRGWI; KLDSKVSGNYNYLYR; ASYQTQTKSHRRARS;IEKSNIIRGWIFGTT; KVSGNYNYLYRLFRK; TQTKSHRRARSVASQ; CEFQFCNDPFLDHKN; FERDISTEIYQAGNK; SHRRARSVASQSIIA; FCNDPFLDHKNNKSW;ISTEIYQAGNKPCNG; LLLQYGSFCTQLKRA; PFLDHKNNKSWMESE; IYQAGNKPCNGVAGF; YGSFCTQLKRALTGI; DGYFKIYSKHTPIIV; GNKPCNGVAGFNCYF;CTQLKRALTGIAVEQ; KIYSKHTPIIVREPE; CNGVAGFNCYFPLKS; KRALTGIAVEQDKNT; KHTPIIVREPEDLPQ; AGFNCYFPLKSYSFR; QVKQIYKTPPIKYFG;IIVREPEDLPQGFSA; CYFPLKSYSFRPTYG; IYKTPPIKYFGGFNF; EPEDLPQGFSALEPL; LKSYSFRPTYGVGHQ; PPIKYFGGFNFSQIL; RFPNITNLCPFDEVF;SFRPTYGVGHQPYRV; YFGGFNFSQILPDPS; ITNLCPFDEVFNATR; TYGVGHQPYRVVVLS; IAARDLICAQKFKGL; CPFDEVFNATRFASV; GHQPYRVVVLSFELL;DLICAQKFKGLTVLP; NCVADYSVLYNLAPF; NKCVNFNFNGLKGTG; AQKFKGLTVLPPLLT; DYSVLYNLAPFFTFK; NFNFNGLKGTGVLTE; KGLTVLPPLLTDEMI;LYNLAPFFTFKCYGV; NGLKGTGVLTESNKK; STASALGKLQDVVNH; APFFTFKCYGVSPTK; PGTNTSNQVAVLYQG; ALGKLQDVVNHNAQA; GDEVRQIAPGQTGNI;TSNQVAVLYQGVNCT; LQDVVNHNAQALNTL; VNHNAQALNTLVKQL; AQALNTLVKQLSSKF; NTLVKQLSSKFGAIS; KQLSSKFGAISSVLN; SKFGAISSVLNDIFS;AISSVLNDIFSRLDK; VLNDIFSRLDKVEAE; IFSRLDKVEAEVQID
Variant Omicron B.1.1.529 Peptide Pool SARS-CoV-2 full length (Spike Glycoprotein)
This peptide pool of the omicron variant of SARS-CoV-2 (315 peptides, delivered in two subpools of 158 & 157 peptides) that covers the whole spike glycoprotein with all mutations.
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.The peptides of this product are supplied lyophilized as trifluoro acetate salts.
Peptide Scan 15/11Length: 1270 amino acidsMFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHVISGTNGTKRFDNPVLPFNDGVYFASIEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPIIVREPEDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFDEVFNATRFASVYAWNRKRISNCVADYSVLYNLAPFFTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGNIADYNYKLPDDFTGCVIAWNSNKLDSKVSGNYNYLYRLFRKSNLKPFERDISTEIYQAGNKPCNGVAGFNCYFPLKSYGFQPTYGVGHQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLKGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEYVNNSYECDIPIGAGICASYQTQTKSHRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLKRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKYFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFKGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNHNAQALNTLVKQLSSKFGAISSVLNDIFSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT
Variant B.1.617.1 (Kappa ) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)
This peptide pool with 25 peptides covers all mutations in the Spike Glycoprotein derived from the kappa variant B.1.617.1 of SARS-CoV-2 which emerged in India in October 2020. Data from the RKI (Germany): India, Oct. 2020: G142D, E154K, L452R, E484Q, D614G, P681R, Q1071H.
Possible applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide purified by solid phase extraction and purity checked by ESI-MS.
Peptide sequences included (each with 25µg):KVCEFQFCNDPFLDV NGVQGFNCYFPLQSY PAHEKNFTTAPAICH FQFCNDPFLDVYYHK GTNTSNQVAVLYQGV NDPFLDVYYHKNNKS SNQVAVLYQGVNCTE LDVYYHKNNKSWMKS AVLYQGVNCTEVPVA YHKNNKSWMKSEFRV QGVNCTEVPVAIHAD NKSWMKSEFRVYSSA GICASYQTQTNSRRR MKSEFRVYSSANNCT SYQTQTNSRRRARSV LDSKVGGNYNYRYRL QTNSRRRARSVASQS VGGNYNYRYRLFRKS RRRARSVASQSIIAY YNYRYRLFRKSNLKP PHGVVFLHVTYVPAH YQAGSTPCNGVQGFN VFLHVTYVPAHEKNF STPCNGVQGFNCYFP VTYVPAHEKNFTTAP
Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
Protein ID: P0DTC2 (swiss prot)
SARS-CoV-2 (Spike Glycoprotein) Peptide Pool - 316 peptides
SARS-CoV-2 (Spike Glycoprotein) Peptide Pool of 316 overlapping peptides (delivered in two subpools of 158 & 158 peptides) derived from a peptide scan (15mers with 11 aa overlap) through Spike glycoprotein (UniProt: P0DTC2) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT).The content of one tube is sufficient for the stimulation of 2.5 x 10E8 cells.
Complete protein sequence of Spike (or Surface) Glycoprotein, Gene name: S (each peptide with about 25µg)
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT
Dissolve in a minimum amount of pure DMSO (approx. 80µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
UniProt: P0DTC2
Variant B.1.617.2 (Delta) Peptide Pool SARS-CoV-2 (Spike Glycoprotein)
The Variant B.1.617.2 (Delta) Peptide Pool SARS-CoV-2 (Spike Glycoprotein) with 27 peptides covers all mutations in the Spike Glycoprotein derived from the delta variant B.1.617.2 of SARS-CoV-2 which is prevalent in India and carries the L452R spike mutation, among others.
Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.
Each peptide purity checked by ESI-MS and purifed by solid phase extraction.
Peptide sequences included (each peptide with 25µg)YHKNNKSWMESEVYS STEIYQAGSKPCNGV TASALGKLQNVVNQN NKSWMESEVYSSANN YQAGSKPCNGVEGFNLGKLQNVVNQNAQAL MESEVYSSANNCTFE SKPCNGVEGFNCYFP QNVVNQNAQALNTLV VYSSANNCTFEYVSQGTNTSNQVAVLYQGV LVLLPLVSSQCVNLR SNQVAVLYQGVNCTE PLVSSQCVNLRTRTQ AVLYQGVNCTEVPVASQCVNLRTRTQLPPA QGVNCTEVPVAIHAD NLRTRTQLPPAYTNS GICASYQTQTNSRRR LDSKVGGNYNYRYRLSYQTQTNSRRRARSV VGGNYNYRYRLFRKS QTNSRRRARSVASQS YNYRYRLFRKSNLKP RRRARSVASQSIIAYERDISTEIYQAGSKP SLSSTASALGKLQNV
Dissolve in a minimum amount of pure DMSO (approx. 40µL) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system.
Protein ID: P0DTC2 (swiss prot)